WSW Helps World Renowned Organization Address Childhood-Onset Non-Communicable Diseases in Sub-Saharan Africa
In Brief
- Secured $15 million in new humanitarian aid—the first new funding in this account in years—overcoming significant institutional bias and succeeding despite a presidential administration proposing draconian cuts to foreign aid.
- Built a powerful bipartisan coalition of congressional champions by developing a compelling geopolitical case that positioned U.S. leadership in global health, in part, as a strategic counter to China’s growing influence in the region.
- Executed a flawless, multi-faceted appropriations campaign, managing the entire process from cultivating champions and submitting requests to strategically engaging in the annual budget process to ensure victory.
WSW was hired to overcome USAID’s institutional bias about new programs to secure $15 million in new federal humanitarian health aid to combat childhood-onset non-communicable diseases in sub-Saharan Africa, including type 1 diabetes, childhood heart disease and sickle cell disease.
WSW developed the most compelling case possible regarding this being one of the regions of the world with the greatest need; a region where, absent U.S. leadership, China will continue to exploit the region for its own strategic gains. Map our client’s relationships in key districts and states to cultivate bipartisan champions in the House and Senate; develop written materials for our meetings; arrange meetings on Capitol Hill and within the Administration for our client; prepare and submit all required appropriations request forms; and track and engage strategically in the annual budget process to ensure our client’s request was well-positioned for consideration.
Working with key bipartisan Members of Congress, WSW secured funding in the FY26 appropriations process. This was the first new funding in this account in years, and we were successful at a time when President Trump abolished USAID and proposed draconian cuts to foreign aid.